Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma Receiving Checkpoint Inhibitors
The NORDIC SUN trial is currently investigating the effectiveness and timing of cytoreductive nephrectomy in patients with newly diagnosed synchronous metastatic renal cell carcinoma (mRCC) being treated with IO-treatment regimens.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
